Department of Spinal Surgery, The Affiliated Hospital of Zunyi Medical University, Zunyi, 563000, Guizhou, China.
Institute of Neurological Disease, Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, 610044, China.
J Orthop Surg Res. 2021 Apr 17;16(1):268. doi: 10.1186/s13018-021-02401-w.
To analyze and compare the effects of peri-treatment analgesics on acute and chronic pain and postoperative functional recovery of patients with thoracolumbar fractures, so as to guide the clinical drug use.
Seven hundred nineteen patients with thoracolumbar fractures were collected and divided into acetaminophen dihydrocodeine, celecoxib, and etoricoxib groups. The main indicators were the degree of postoperative pain (visual analog scale (VAS)), the incidence of chronic pain and postoperative functional recovery (Oswestry dysfunction index (ODI) and Japanese Orthopedics Association score (JOA)), which were continuously tracked through long-term telephone follow-up. The correlation analysis of ODI-pain score, peri-treatment VAS score, and ODI index was performed, and bivariate regression analysis was conducted to understand the risk factors for chronic pain.
Regression analysis showed that severe spinal cord injury and peri-treatment use of acetaminophen dihydrocodeine were both one of the risk factors for postoperative chronic pain. But there were no statistically conspicuous differences in basic characteristics, preoperative injury, and intraoperative conditions. Compared with the other two groups, patients in the acetaminophen dihydrocodeine group had longer peri-therapeutic analgesic use, higher pain-related scores (VAS 1 day preoperatively, VAS 1 month postoperatively, and ODI-pain 1 year postoperatively), higher VAS variation, higher incidence of chronic pain 1 year after surgery, and higher ODI index. And other ODI items and JOA assessments showed no statistically significant differences. In addition, the correlation analysis showed that the peri-treatment pain score was correlated with the severity of postoperative chronic pain.
Although the peri-treatment analgesic effect of acetaminophen dihydrocodeine is good, it is still necessary to combine analgesics with different mechanisms of action for patients with severe preoperative pain of thoracolumbar fracture, so as to inhibit the incidence of postoperative chronic pain and improve the quality of postoperative rehabilitation.
分析和比较围治疗期镇痛药物对胸腰椎骨折患者急性和慢性疼痛及术后功能恢复的影响,以指导临床用药。
收集 719 例胸腰椎骨折患者,分为对乙酰氨基酚氢可酮、塞来昔布和依托考昔组。主要指标为术后疼痛程度(视觉模拟评分(VAS))、慢性疼痛发生率和术后功能恢复(Oswestry 功能障碍指数(ODI)和日本骨科协会评分(JOA)),通过长期电话随访进行连续跟踪。对 ODI-疼痛评分、围治疗期 VAS 评分和 ODI 指数进行相关性分析,并进行二元回归分析以了解慢性疼痛的危险因素。
回归分析显示,严重脊髓损伤和围治疗期使用对乙酰氨基酚氢可酮是术后慢性疼痛的危险因素之一。但在基本特征、术前损伤和术中情况方面均无统计学显著性差异。与其他两组相比,对乙酰氨基酚氢可酮组围治疗期镇痛药物使用时间更长,疼痛相关评分(术前 1 天 VAS、术后 1 个月 VAS 和术后 1 年 ODI-pain)更高,VAS 变化更大,术后 1 年慢性疼痛发生率更高,ODI 指数更高。其他 ODI 项目和 JOA 评估无统计学显著性差异。此外,相关性分析表明,围治疗期疼痛评分与术后慢性疼痛的严重程度相关。
虽然对乙酰氨基酚氢可酮的围治疗期镇痛效果良好,但对于术前疼痛严重的胸腰椎骨折患者仍需结合不同作用机制的镇痛药物,以抑制术后慢性疼痛的发生,提高术后康复质量。